Amphastar Pharmaceuticals (AMPH) Treasury Shares (2014 - 2026)

Amphastar Pharmaceuticals' Treasury Shares history runs 13 years deep, the most recent figure standing at $30.0 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 167.4% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was $30.0 million, a 167.4% increase from a year earlier, with the FY2025 full-year figure at $408.1 million, up 377.6% from the prior year.
• Treasury Shares eased to $30.0 million in Q1 2026 per AMPH's latest filing, from $408.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at -$10.0 million in Q4 2022 and bottomed at -$17.5 million in Q1 2026.
• The 5-year median for Treasury Shares is -$13.2 million (2024), against an average of -$13.4 million.
• Across the five-year window, Treasury Shares tumbled 97.89% in 2023 and jumped 6487.6% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $39.9 million in 2022, then soared by 45.69% to $58.1 million in 2023, then soared by 46.98% to $85.5 million in 2024, then surged by 377.6% to $408.1 million in 2025, then slumped by 92.65% to $30.0 million in 2026.
• Per Business Quant, the three latest AMPH Treasury Shares figures stand at $30.0 million (Q1 2026), $408.1 million (Q4 2025), and $4.8 million (Q3 2025).